Abstracts

1244 – Syphilis Among Women of Reproductive Age With or Without HIV in the Southern US

Background Syphilis is associated with increased risk of HIV acquisition and poor pregnancy outcomes, including congenital syphilis. Syphilis remains a threat to public health despite accessible screening and treatment. This study examines the prevalence of syphilis among reproductive-age (18-45 years) women with or without HIV enrolled between 2021 and 2023 in the Study of Treatment…

1285 – Antimicrobial Resistance of N. gonorrhoeae at a Community-Based Clinic, 2023-2024

Background Gonorrhea, caused by N. gonorrhoeae, has developed resistance to most antimicrobial treatments over time, including ciprofloxacin, tetracycline, penicillin, and cephalosporins. Importantly, baseline tetracycline resistance may impact the use of doxycycline as post-exposure prophylaxis (DoxyPEP) to prevent bacterial STIs. We evaluated baseline N. gonorrhoeae resistance in patients presenting to a community-based STI clinic. Methods We…

1261 – Probability of Anal Human Papillomavirus Infection Following Acute HIV Acquisition in Thailand

Background Anal cancer is largely contributed by anal high-risk human papillomavirus (HRHPV) infection, especially human papillomavirus (HPV) 16. This study described HPV progression among individuals with acute HIV acquisition. Methods From May 2017 to June 2020, participants who initiated antiretroviral therapy during acute HIV acquisition (Fiebig stages 1–5) and consented to anal HPV genotyping and…

1268 – Depressive Symptoms on the Incidence of Sexually Transmitted Infections Among Reproductive-Age Women

Background Prior research has suggested that depressive symptoms may be related to incidence of sexually transmitted infections (STIs) among women, but the patterns have not been consistent and the types of comparisons that have been made are limited. Here, we address this knowledge gap by estimating the dose-response relationship between depressive symptoms and the 6-month…

1265 – Diagnostic Screening and Treatment of Curable STIs in Pregnancy and Impact on Pregnancy Outcomes

Background Sexually transmitted infections (STIs) during pregnancy are associated with adverse pregnancy outcomes. We evaluated the impact of diagnosing and treating curable STIs (Chlamydia [CT]/Gonorrhoea [NG]) during pregnancy on adverse pregnancy outcomes among women in a HIV pre-exposure prophylaxis (PrEP) cohort study in Cape Town, South Africa. Methods Eligible women >16 years, attending antenatal care, without…

1271 – Asymptomatic Sexually Transmitted Infections in a Population of High-Risk Men Who Have Sex With Men

Background Sexually transmitted infections (STIs) represent a major public health challenge, particularly as many cases are asymptomatic, complicating early detection, treatment, and partner notification, and contributing to ongoing transmission. This study aims to examine the role of asymptomatic STIs in a high-risk population of men who have sex with men (MSM), who regularly undergo STI…

1247 – Has Rapid Scale-Up of Dual HIV/Syphilis Testing in Antenatal Care Improved Syphilis Testing Coverage?

Background In 2022 there were approximately 130,000 child HIV infections and 700,000 cases of congenital syphilis globally. Through concerted effort substantial progress has been made in both HIV and syphilis testing coverage to identify infections in pregnancy and to offer treatment. However, gaps remain, including the gap between HIV and syphilis testing. Dual HIV/syphilis rapid…

1262 – Incidence and Clearance of Anal Human Papillomavirus Infection in an Acute HIV Cohort in Thailand

Background Anal high-risk human papillomavirus (HRHPV) infection, especially human papillomavirus (HPV) 16, is the leading cause of anal cancer. This study explored factors associated with HRHPV incidence and clearance among individuals with acute HIV acquisition. Methods Participants who initiated antiretroviral therapy during acute HIV acquisition, defined as Fiebig stages 1–5, and agreed to undergo anal…